These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 10424375)

  • 1. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
    Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
    Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased platelet and coagulatory activity in peripheral atherosclerosis flow mediated platelet function is a sensitive and specific disease indicator.
    Reininger CB; Graf J; Reininger AJ; Spannagl M; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Dec; 15(4):335-43. PubMed ID: 9127775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of platelet function using stagnation point flow aggregometry. First clinical results.
    Reininger CB; Reininger AJ; Hörmann A; Steckmeier B; Schweiberer L
    Int Angiol; 1992; 11(4):247-55. PubMed ID: 1295930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelets of patients with peripheral arterial disease demonstrate a hypersensitive response to heparin.
    Reininger CB; Greinacher A; Eibl-Eibesfeldt B; Lasser R; Steckmeier B; Schweiberer L
    Int Angiol; 1996 Sep; 15(3):207-14. PubMed ID: 8971577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of two synthetic glycoprotein IIb/IIIa antagonists, Ro 43-8857 and L-700,462, on platelet aggregation and bleeding in guinea-pigs and dogs: evidence that Ro 43-8857 is orally active.
    Cook NS; Bruttger O; Pally C; Hagenbach A
    Thromb Haemost; 1993 Nov; 70(5):838-47. PubMed ID: 8128443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycoprotein IIb-IIIa content and platelet aggregation in healthy volunteers and patients with acute coronary syndrome.
    Yakushkin VV; Zyuryaev IT; Khaspekova SG; Sirotkina OV; Ruda MY; Mazurov AV
    Platelets; 2011; 22(4):243-51. PubMed ID: 21329420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Increased pre- and postoperative thrombocyte activity in vascular surgery patients].
    Reininger CB; Reininger AJ; Steckmeier B; Lasser R; Schweiberer L
    Vasa; 1994; 23(3):217-27. PubMed ID: 7975867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fibrinogen substitution in afibrinogenemia on hemorheology and platelet function.
    Reininger AJ; Reininger CB; Spannagl M; Mellinghoff A; Porr A; Heinzmann U; Wurzinger LJ
    Thromb Haemost; 1995 Sep; 74(3):853-8. PubMed ID: 8571310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
    Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
    Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion of ADP-activated platelets to intact endothelium under stagnation point flow in vitro is mediated by the integrin alphaIIbeta3.
    Reininger AJ; Korndörfer MA; Wurzinger LJ
    Thromb Haemost; 1998 May; 79(5):998-1003. PubMed ID: 9609236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spreading of platelets: a morphological marker for platelet reactivity in peripheral arterial occlusive disease.
    Reininger AJ; Reininger CB; Agneskirchner J; Scherb H; Spannagl M; Wurzinger LJ
    Platelets; 1998; 9(3-4):241-4. PubMed ID: 16793710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased platelet purinergic sensitivity in peripheral arterial disease--a pilot study.
    Braun OO; Jagroop A; Wang L; Mikhailidis DP; Burnstock G; Erlinge D
    Platelets; 2005 Aug; 16(5):261-7. PubMed ID: 16011976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb.
    Massberg S; Schürzinger K; Lorenz M; Konrad I; Schulz C; Plesnila N; Kennerknecht E; Rudelius M; Sauer S; Braun S; Kremmer E; Emambokus NR; Frampton J; Gawaz M
    Circulation; 2005 Aug; 112(8):1180-8. PubMed ID: 16103235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased platelet adhesion under flow conditions is induced by both thalassemic platelets and red blood cells.
    Goldschmidt N; Spectre G; Brill A; Zelig O; Goldfarb A; Rachmilewitz E; Varon D
    Thromb Haemost; 2008 Nov; 100(5):864-70. PubMed ID: 18989531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of roxifiban on platelet aggregation and major receptor expression in patients with coronary artery disease for the Roxifiban Oral Compound Kinetics Evaluation Trial-I (ROCKET-I Platelet Substudy).
    Serebruany VL; Malinin AI; O'connor CM; Gurbel PA;
    Am Heart J; 2003 Jul; 146(1):91-8. PubMed ID: 12851613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of peripheral arterial disease on circulating platelets.
    McBane RD; Karnicki K; Miller RS; Owen WG
    Thromb Res; 2004; 113(2):137-45. PubMed ID: 15115669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
    Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
    Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of arterial thrombus formation in two canine models: comparison of ancrod, a fibrinogen-depleting agent, the thrombin-inhibitor r-hirudin, and the glycoprotein 11b/IIIa-receptor antagonist Ro 43-8857.
    Rübsamen K; Hornberger W; Kirchengast M
    Thromb Haemost; 1995 Nov; 74(5):1353-60. PubMed ID: 8607122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycoprotein Ibalpha-mediated platelet adhesion and aggregation to immobilized thrombin under conditions of flow.
    Weeterings C; Adelmeijer J; Myles T; de Groot PG; Lisman T
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):670-5. PubMed ID: 16357309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.